(Q80586582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Schindlbeck C

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Janni W

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Shabani N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rack B

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Gerber B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Schmitt M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Harbeck N

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sommer H

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Braun S

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Friese K

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

65-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15377852%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/b:brea.0000041583.72269.e1

1 January 2020

exact match

0 references

cites work

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Molecular determinants of occult metastatic tumor cells in bone marrow

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

The ErbB receptors and their role in cancer progression.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Current status of HER2 testing

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

The clinical evaluation of HER-2 status: which test to use?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Testing for HER2 status

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Soluble and matrix-associated heparan sulfate proteoglycans increase expression of erb-B2 and erb-B3 in colon cancer cell lines

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Assessment of HER‐2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Prognostic value of c-erbB2 expression in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

HER2 as a prognostic and predictive marker for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

The development and clinical use of trastuzumab (Herceptin).

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000041583.72269.E1

7 January 2021